Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
More Clinical Benefits With Tirzepatide vs GLP-1 RA in T2D
TOPLINE: In patients with type 2 diabetes (T2D), tirzepatide is associated with a reduced risk for all-cause mortality, major adverse cardiovascular events (MACEs), major adverse kidney events, and acute kidney injury compared with glucagon-like peptide 1 receptor agonists (GLP-1 RAs).…
English